Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

11 Feb 2012

Abstract excerpt

PURPOSE: Neuroblastoma is an embryonal tumor with contrasting clinical courses. Despite elaborate stratification strategies, precise clinical risk assessment still remains a challenge. The purpose of this study was to develop a PCR-based predictor model to improve clinical risk assessment of patients with neuroblastoma. EXPERIMENTAL DESIGN: The model was developed using real-time PCR gene expression data from 96...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22328561
DOI: 10.1158/1078-0432.ccr-11-2483

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Three-Gene Expression Signature Model for Risk Stratification of Patients with NeuroblastomaPMID 22328561Read ↗

Prognostic Impact of Gene Expression–Based Classification for NeuroblastomaSemantic proximity Read ↗

Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profilesSemantic proximity Read ↗

High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in NeuroblastomaSemantic proximity Read ↗

Identification of prognostic biomarkers in neuroblastoma using WGCNA and multi-omics analysisSemantic proximity Read ↗

Identification of Potential Prognostic Genes for NeuroblastomaSemantic proximity Read ↗

Bioinformatics identification of key genes associated with risk and prognosis of neuroblastomaSemantic proximity Read ↗

Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastomaSemantic proximity Read ↗

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor SamplesSemantic proximity Read ↗

Advances in Risk Classification and Treatment Strategies for NeuroblastomaSemantic proximity Read ↗

Clinically Relevant Biomarker Discovery in High-Risk Recurrent NeuroblastomaSemantic proximity Read ↗

Global genomic and RNA profiles for novel risk stratification of neuroblastoma.Semantic proximity Read ↗

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk StratificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.